A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in The
medRxiv preprint doi: https://doi.org/10.1101/2021.04.15.21255300; this version posted April 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. A Feasibility Trial to Evaluate the Composite Efficacy of Inhaled Nitric Oxide in the Treatment of Covid 19 Pneumonia : Impact on Viral Load and Clinical Outcomes Merlin Moni, MD1, Thushara Madathil, DM2, Dipu T Sathyapalan, MD1, Veena Menon, PhD3, Georg Gutjahr, PhD4, Fabia Edathadathil, MSc5, Deepthi Sureshkumar, MBBS6, Preetha Prasanna, MBA1, Soumya Jose, MSc3, Roshni Jerome, MSc3, Ajai Krishnan, MSc3, Indulekha C Pillai, PhD7, Geetha Kumar, PhD7, Bipin Nair, PhD8, Aveek Jayant, DM1 1Department of Medicine, Division of Infectious Diseases, Amrita Institute of Medical Science, Am- rita Vishwa Vidyapeetham, Kochi 682041, Kerala, India 2Department of Cardiac Anaesthesiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India 3Clinical Virology Laboratory, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India 4Georg Gutjahr, Centre for Research in Analytics and Technologies for Education (CREATE), Amrita Vishwa Vidyapeetham, Amritapuri, Kollam 690546, Kerala, India 5Fabia Edathadathil, Department of Infection Control and Epidemiology, Amrita Institute of Medical Science, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India 6School
[Show full text]